UCLA Team Builds Microfluidic Platform for Measuring Protein Kinase Activity
November 19, 2010
UCLA Team Builds Microfluidic Platform for Measuring Protein Kinase Activity
The platform, which the scientists used to measure ABL kinase activity in BCR-ABL-positive leukemia patient samples, could potentially be expanded into a multiplex version for use in high-throughput kinase studies, said one of its developers.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- UCLA Study Identifies Leukemia Pathways Potentially Involved in Gleevec Resistance
March 25, 2011 / ProteoMonitor - Prometheus Labs, UCLA Collaborate on IBD Markers
December 10, 2010 / GenomeWeb Daily News - Startup CytoScale Diagnostics to Commercialize UCLA's Single-Cell Protein Biomarker Platform
August 6, 2010 / ProteoMonitor - Phosphoproteomic Profiling Suggests Src Inhibitors Useful as Kidney Cancer Treatment
June 3, 2011 / ProteoMonitor - Samples Available for PRG 2012 Intra-Lab QC and Reproducibility Study
January 13, 2012 / ProteoMonitor